Sign in
4

Changes in Ownership

MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0000899243-24-000243

Director sold 32,489 shares at an average $252.97 ($8,218,630)

  • Director acquired 32,489 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Daly James M Director 2024-04-01 Option exercise 10b5-1 +20,000 $100.45 $2,009,000 21,198 D: show line 1 in the form
Daly James M Director 2024-04-01 Option exercise 10b5-1 +1,577 $105.08 $165,711 22,775 D: show line 2 in the form
Daly James M Director 2024-04-01 Sale 10b5-1 −6,809 $255.64 $1,740,630 15,966 D: show line 3 in the form
Daly James M Director 2024-04-01 Sale 10b5-1 −7,401 $256.50 $1,898,371 8,565 D: show line 4 in the form
Daly James M Director 2024-04-01 Sale 10b5-1 −3,604 $257.30 $927,302 4,961 D: show line 5 in the form
Daly James M Director 2024-04-01 Sale 10b5-1 −1,460 $258.28 $377,094 3,501 D: show line 6 in the form
Daly James M Director 2024-04-01 Sale 10b5-1 −200 $259.11 $51,822 3,301 D: show line 7 in the form
Daly James M Director 2024-04-01 Sale 10b5-1 −800 $262.01 $209,604 2,501 D: show line 8 in the form
Open-market sales · 32,489 sh · avg $252.97 · $8,218,630

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Daly James M Director 2024-04-01 Option exercise · Stock Option (Right to Buy) 10b5-1 −20,000 0 D: show line 20 in the form
Daly James M Director 2024-04-01 Option exercise · Stock Option (Right to Buy) 10b5-1 −1,577 10,912 D: show line 21 in the form
Daly James M Director 2024-04-02 Option exercise · Stock Option (Right to Buy) 10b5-1 −10,912 0 D: show line 22 in the form
Loading xslF345X05/doc4.xml…